371 results on '"Glatz, Jan F.C."'
Search Results
2. Glycolysis-Mediated Activation of v-ATPase by Nicotinamide Mononucleotide Ameliorates Lipid-Induced Cardiomyopathy by Repressing the CD36-TLR4 Axis
3. Specific amino acid supplementation rescues the heart from lipid overload-induced insulin resistance and contractile dysfunction by targeting the endosomal mTOR–v-ATPase axis
4. Understanding the distinct subcellular trafficking of CD36 and GLUT4 during the development of myocardial insulin resistance
5. Re-balancing cellular energy substrate metabolism to mend the failing heart
6. Metabolic Profiling Associates with Disease Severity in Nonischemic Dilated Cardiomyopathy
7. Fatty Acids Prevent Hypoxia-Inducible Factor-1α Signaling Through Decreased Succinate in Diabetes
8. WITHDRAWN: The Endocannabinoid System: Overview of an Emerging Multi-faceted Therapeutic Target
9. Cardiac contraction-induced GLUT4 translocation requires dual signaling input
10. Protein kinase-D1 overexpression prevents lipid-induced cardiac insulin resistance
11. Cardiac troponin in ischemic cardiomyocytes: Intracellular decrease before onset of cell death
12. Diabetic db/db mice do not develop heart failure upon pressure overload: a longitudinal in vivo PET, MRI, and MRS study on cardiac metabolic, structural, and functional adaptations
13. Inhibition of sarcolemmal FAT/CD36 by sulfo-N-succinimidyl oleate rapidly corrects metabolism and restores function in the diabetic heart following hypoxia/reoxygenation
14. CD36 (SR-B2) as master regulator of cellular fatty acid homeostasis
15. Basics in Metabolically Relevant Biochemistry
16. List of Contributors
17. Cardiac multi-marker strategy for effective diagnosis of acute myocardial infarction
18. Good and bad consequences of altered fatty acid metabolism in heart failure: evidence from mouse models
19. Greater Transport Efficiencies of the Membrane Fatty Acid Transporters FAT/CD36 and FATP4 Compared with FABPpm and FATP1 and Differential Effects on Fatty Acid Esterification and Oxidation in Rat Skeletal Muscle
20. CD36 as a target for metabolic modulation therapy in cardiac disease
21. Differential regulation of cardiac glucose and fatty acid uptake by endosomal pH and actin filaments
22. Restoring AS160 phosphorylation rescues skeletal muscle insulin resistance and fatty acid oxidation while not reducing intramuscular lipids
23. Cardiac and skeletal muscle fatty acid transport and transporters and triacylglycerol and fatty acid oxidation in lean and Zucker diabetic fatty rats
24. FAT/CD36-null mice reveal that mitochondrial FAT/CD36 is required to upregulate mitochondrial fatty acid oxidation in contracting muscle
25. In obese rat muscle transport of palmitate is increased and is channeled to triacylglycerol storage despite an increase in mitochondrial palmitate oxidation
26. Comparison of human and rodent cell models to study myocardial lipid-induced insulin resistance
27. Cardiac dysfunction and cell damage across clinical stages of severity in growth-restricted fetuses
28. Two phases of palmitate-induced insulin resistance in skeletal muscle: impaired GLUT4 translocation is followed by a reduced GLUT4 intrinsic activity
29. Metabolic challenges reveal impaired fatty acid metabolism and translocation of FAT/CD36 but not FABPpm in obese Zucker rat muscle
30. A null mutation in skeletal muscle FAT/CD36 reveals its essential role in insulin- and AICAR-stimulated fatty acid metabolism
31. Fatty acid transport and FAT/CD36 are increased in red but not in white skeletal muscle of ZDF rats
32. Identification of fatty acid translocase on human skeletal muscle mitochondrial membranes: essential role in fatty acid oxidation
33. Release of brain-type and heart-type fatty acid-binding proteins in serum after acute ischaemic stroke
34. Insulin stimulates fatty acid transport by regulating expression of FAT/CD36 but not FABPpm
35. Different mechanisms can alter fatty acid transport when muscle contractile activity is chronically altered
36. Regulation of fatty acid transport and membrane transporters in health and disease
37. Cellular lipid binding proteins as facilitators and regulators of lipid metabolism
38. Evolution of the family of intracellular lipid binding proteins in vertebrates
39. Critical steps in cellular fatty acid uptake and utilization
40. Sulfo-N-succinimidyl esters of long chain fatty acids specifically inhibit fatty acid translocase (FAT/CD36)-mediated cellular fatty acid uptake
41. A null mutation in H-FABP only partially inhibits skeletal muscle fatty acid metabolism
42. The responses of fatty acid-binding protein and creatine kinase to acute and chronic exercise in junior rowers
43. Myocardial recovery from ischemia is impaired in CD36-null mice and restored by myocyte CD36 expression or medium-chain fatty acids
44. Plasma markers of activated hemostasis in the early diagnosis of acute coronary syndromes
45. Plasma heart-type fatty acid binding protein is superior to troponin and myoglobin for rapid risk stratification in acute pulmonary embolism
46. Changes in fatty acid transport and transporters are related to the severity of insulin deficiency
47. Insulin induces the translocation of the fatty acid transporter FAT/CD36 to the plasma membrane
48. Cytochrome P450, peroxisome proliferation, and cytoplasmic fatty acid-binding protein content in liver, heart and kidney of the diabetic rat
49. Targeting metabolic pathways to treat cardiovascular diseases
50. Time for a détente in the war on the mechanism of cellular fatty acid uptake
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.